Search

Introduction: frequently after kidney transplantation there is an increase in weight with a resulting high percent of obesity in these recipients. This combined with a rapid loss of bone mass, a higher prevalence of osteoporosis and fractures is evident than in normal populations. Objectives: to explore the relationship between body mass index (BMI) and prevalence of osteoporosis in a population of renal transplant recipients. Methods: prospective longitudinal study design. The study was conducted on 306 kidney transplant recipients. The relationship between weigh and body mass index with femoral and lumbar osteopenia and osteoporosis prevalence at the moment of transplant and at 12 months post was explored. Results: there was a high prevalence of overweight (35.6%) and obese (14.1%) recipients after renal transplant and 1 year after (42.2% and 24.2% respectively). Significant differences were found(p = 0.049) between the weight at the time of transplant and the presence of osteopenia or osteoporosis at the lumbar level one year after, the highest weights were in recipients with osteoporosis. The mean BMI was higher (p = 0.028) in osteoporotic patients (26.59 kg/m2) than in patients with osteopenia (24.23 kg/m2). Conclusion: results seem to be consistent with recent studies in the general population showing excessive weight as a possible factor detrimental to the bone health. [ABSTRACT FROM AUTHOR]

Introduction: The onset of post-transplant diabetes mellitus (PTDM) among kidney recipients is associated with an increased risk of graft failure and high rates of morbidity and mortality. Minimize the risk of PTDM is a priority for improving long-term survival rates. Aims. This study aims to assess the prevalence of PTDM in a renal transplant patient population, to identify risk factors and assess the graft and patient survival. Methods: The sample consisted of 112 renal transplant patients , 69 men and 43 women , renal transplant, who attended for five years post-transplant consultation. Were analyzed as potential risk factors for PTDM : age , sex, body mass index (BMI) , obesity , VHC , hypertension, dyslipidemia , total cholesterol (TC), serum triglyceride and immunosuppressive therapy ( cyclosporine , tacrolimus , mycophenolate mofetil and sirolimus ), also the prevalence of acute rejection episodes was evaluated. Results: The prevalence of PTDM was 24.2 %, compared with 85 patients (75.8%) with standard glucose (PGN). PTDM patients showed a higher BMI, a higher percentage of overweight, dyslipidemia, total cholesterol levels , triglycerides and performed a greater percentage of patients with PDMPT including Mycophenolate mofetil was administered. Conclusions: There is a high incidence of PTDM in kidney recipients , the importance of weight control and strict adherence to all identified risk factors, as well as in minimizing the doses of immunosuppressive therapies to prevent the onset of PTDM. [ABSTRACT FROM AUTHOR]